These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20131760)

  • 1. Thermodynamics of multivalent interactions: influence of the linker.
    Kane RS
    Langmuir; 2010 Jun; 26(11):8636-40. PubMed ID: 20131760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the nature of the multivalency effect: a thermodynamic model.
    Kitov PI; Bundle DR
    J Am Chem Soc; 2003 Dec; 125(52):16271-84. PubMed ID: 14692768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Prediction of Multivalent Ligand-Receptor Binding Affinities for Influenza, Cholera, and Anthrax Inhibition.
    Liese S; Netz RR
    ACS Nano; 2018 May; 12(5):4140-4147. PubMed ID: 29474056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of effective molarity on linker length for an intramolecular protein-ligand system.
    Krishnamurthy VM; Semetey V; Bracher PJ; Shen N; Whitesides GM
    J Am Chem Soc; 2007 Feb; 129(5):1312-20. PubMed ID: 17263415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent ligand: design principle for targeted therapeutic delivery approach.
    Chittasupho C
    Ther Deliv; 2012 Oct; 3(10):1171-87. PubMed ID: 23116010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Insights into Avidity of Polymeric Multivalent Binders.
    Zumbro E; Witten J; Alexander-Katz A
    Biophys J; 2019 Sep; 117(5):892-902. PubMed ID: 31400918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of thermodynamic effects of carbohydrate multivalency on avidity using synthetic discrete glycooligomers.
    Nagao M; Hoshino Y; Miura Y
    Chem Commun (Camb); 2024 Jul; 60(55):7021-7024. PubMed ID: 38895769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linker Dependence of Avidity in Multivalent Interactions Between Disordered Proteins.
    Sørensen CS; Jendroszek A; Kjaergaard M
    J Mol Biol; 2019 Dec; 431(24):4784-4795. PubMed ID: 31518611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring Multivalent Binding Interactions by Isothermal Titration Calorimetry.
    Dam TK; Talaga ML; Fan N; Brewer CF
    Methods Enzymol; 2016; 567():71-95. PubMed ID: 26794351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalency effects in protein--carbohydrate interaction: the binding of the Shiga-like toxin 1 binding subunit to multivalent C-linked glycopeptides.
    Lundquist JJ; Debenham SD; Toone EJ
    J Org Chem; 2000 Dec; 65(24):8245-50. PubMed ID: 11101380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additivity and the physical basis of multivalency effects: a thermodynamic investigation of the calcium EDTA interaction.
    Christensen T; Gooden DM; Kung JE; Toone EJ
    J Am Chem Soc; 2003 Jun; 125(24):7357-66. PubMed ID: 12797810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity and surface mobility in multivalent ligand-receptor binding.
    Merminod S; Edison JR; Fang H; Hagan MF; Rogers WB
    Nanoscale; 2021 Aug; 13(29):12602-12612. PubMed ID: 34259699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
    Bobrovnik SA
    J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of multivalent glycoconjugate-lectin interaction: An update.
    Dam TK; Hohman O; Sheppard L; Brewer CF; Bandyopadhyay P
    Adv Carbohydr Chem Biochem; 2023; 84():1-21. PubMed ID: 37979977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of monodisperse and well-defined polypeptide-based polyvalent inhibitors of anthrax toxin.
    Patke S; Boggara M; Maheshwari R; Srivastava SK; Arha M; Douaisi M; Martin JT; Harvey IB; Brier M; Rosen T; Mogridge J; Kane RS
    Angew Chem Int Ed Engl; 2014 Jul; 53(31):8037-40. PubMed ID: 24706570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions.
    Liu J; Begley D; Mitchell DD; Verlinde CLMJ; Varani G; Fan E
    Chem Biol Drug Des; 2008 May; 71(5):408-419. PubMed ID: 18373548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mannose/N-acetylgalactosamine-4-SO4 receptor displays greater specificity for multivalent than monovalent ligands.
    Roseman DS; Baenziger JU
    J Biol Chem; 2001 May; 276(20):17052-7. PubMed ID: 11279168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of linker length and flexibility on multivalent targeting.
    Shewmake TA; Solis FJ; Gillies RJ; Caplan MR
    Biomacromolecules; 2008 Nov; 9(11):3057-64. PubMed ID: 18828631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for describing the thermodynamics of multivalent host-guest interactions at interfaces.
    Huskens J; Mulder A; Auletta T; Nijhuis CA; Ludden MJ; Reinhoudt DN
    J Am Chem Soc; 2004 Jun; 126(21):6784-97. PubMed ID: 15161307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multivalent effect in glycosidase inhibition: probing the influence of valency, peripheral ligand structure, and topology with cyclodextrin-based iminosugar click clusters.
    Decroocq C; Joosten A; Sergent R; Mena Barragán T; Ortiz Mellet C; Compain P
    Chembiochem; 2013 Oct; 14(15):2038-49. PubMed ID: 24014313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.